Ftse Mib
34.660,38
-0,50%
DAX
18.557,27
-0,48%
S&P 500
5.346,99
-0,11%
NASDAQ
17.133,13
-0,23%
Bitcoin
69.342,01
0,01%
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ BriaCell Therapeutics Corporation (BCTXW) BriaCell Therapeutics Corporation (BCTXW) Notizie

BCTXW

BriaCell Therapeutics (BCTXW)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:BCTXW
DataOraFonteTitoloSimboloCompagnia
03/06/202414:00GlobeNewswire Inc.BriaCell Presents Clinical Efficacy Data at ASCO 2024NASDAQ:BCTXWBriaCell Therapeutics Corporation
30/05/202414:00GlobeNewswire Inc.BriaCell Initiates Patient Enrollment in First-in-Human Study of Bria-OTS™ in Advanced Metastatic Breast CancerNASDAQ:BCTXWBriaCell Therapeutics Corporation
28/05/202414:00GlobeNewswire Inc.BriaCell Announces Clinical Supply Agreement with BeiGene for Bria-OTS™ First in Human StudyNASDAQ:BCTXWBriaCell Therapeutics Corporation
24/05/202414:58Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:BCTXWBriaCell Therapeutics Corporation
24/05/202414:00GlobeNewswire Inc.BriaCell Doubles Progression-Free-Survival (PFS) and Reports Clinical Benefit Data at ASCO 2024NASDAQ:BCTXWBriaCell Therapeutics Corporation
20/05/202422:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BCTXWBriaCell Therapeutics Corporation
17/05/202422:51Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BCTXWBriaCell Therapeutics Corporation
17/05/202422:33GlobeNewswire Inc.BriaCell Therapeutics Announces Closing of $5.0 Million Registered Direct OfferingNASDAQ:BCTXWBriaCell Therapeutics Corporation
16/05/202423:10Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:BCTXWBriaCell Therapeutics Corporation
15/05/202414:00GlobeNewswire Inc.BriaCell Therapeutics Announces Pricing of $5.0 Million Registered Direct OfferingNASDAQ:BCTXWBriaCell Therapeutics Corporation
24/04/202414:00GlobeNewswire Inc.BriaCell Announces Oral and Poster Presentations at ASCO 2024NASDAQ:BCTXWBriaCell Therapeutics Corporation
10/04/202414:00GlobeNewswire Inc.BriaCell 2024 AACR Preclinical Poster Confirms Strong Anti-Cancer Activity of Bria-OTS+™ and Bria-PROS+™ Clinical Candidates for Breast and Prostate CancerNASDAQ:BCTXWBriaCell Therapeutics Corporation
09/04/202414:00GlobeNewswire Inc.BriaCell Showcases Data Demonstrating Unmatched Progression-Free Survival (PFS) and Clinical Efficacy in Antibody-Drug Conjugate (ADC) Resistant and Central Nervous System (CNS) Metastatic Breast Cancer at the 2024 AACRNASDAQ:BCTXWBriaCell Therapeutics Corporation
07/03/202414:00GlobeNewswire Inc.BriaCell Receives and Executes Letter of Intent to Advance Clinical Development of Breast and Prostate Cancer ImmunotherapiesNASDAQ:BCTXWBriaCell Therapeutics Corporation
06/03/202414:00GlobeNewswire Inc.BriaCell to Present Clinical Data in Central Nervous System (CNS) Metastasis and Antibody-Drug Conjugate (ADC) Resistant Breast Cancer at the 2024 AACR ConferenceNASDAQ:BCTXWBriaCell Therapeutics Corporation
27/02/202414:00GlobeNewswire Inc.BriaCell Provides Update on Alleged Illegal Trading of Public SecuritiesNASDAQ:BCTXWBriaCell Therapeutics Corporation
07/02/202414:00GlobeNewswire Inc.BriaCell Announces Strong Clinical Data in Breast Cancer Patients; Reports Another Notable Responder CaseNASDAQ:BCTXWBriaCell Therapeutics Corporation
06/02/202414:30GlobeNewswire Inc.Breaking Ground in Prostate Cancer: BriaCell Announces Lead Prostate Cancer Candidate Bria-Pros+, Initiates GMP ManufacturingNASDAQ:BCTXWBriaCell Therapeutics Corporation
31/01/202404:48GlobeNewswire Inc.BriaCell Therapeutics Corp. Announces Results of Shareholder MeetingNASDAQ:BCTXWBriaCell Therapeutics Corporation
04/01/202414:45GlobeNewswire Inc.BriaCell Images Confirm Robust Anti-Tumor Activity in Patient with “Eye-Bulging” Metastatic Breast CancerNASDAQ:BCTXWBriaCell Therapeutics Corporation
28/12/202314:55GlobeNewswire Inc.BriaCell Reports 71% Central Nervous System Response Rate in Advanced Breast Cancer PatientsNASDAQ:BCTXWBriaCell Therapeutics Corporation
20/12/202314:40GlobeNewswire Inc.BriaCell Reports Unprecedented Preliminary Survival and Clinical Benefit in Antibody-Drug Conjugate (ADC) Refractory Patient SubsetNASDAQ:BCTXWBriaCell Therapeutics Corporation
06/12/202315:31GlobeNewswire Inc.BriaCell Highlights Outstanding Topline Survival and Clinical Benefit Data in Advanced Metastatic Breast Cancer at the 2023 SABCSNASDAQ:BCTXWBriaCell Therapeutics Corporation
06/12/202315:00GlobeNewswire Inc.BriaCell 2023 SABCS Posters Confirm Activation of Cancer-Fighting Immune Cells and Identify Potential Predictors of Clinical BenefitNASDAQ:BCTXWBriaCell Therapeutics Corporation
30/11/202313:00GlobeNewswire Inc.BriaCell Records New Responder with Remarkable Improvement of “Eye-Bulging” Metastatic TumorNASDAQ:BCTXWBriaCell Therapeutics Corporation
03/11/202313:31GlobeNewswire Inc.BriaCell Reports Unprecedented Anti-Tumor Activity of its Next Generation Personalized Breast and Prostate Cancer Immunotherapies in Tumor Models at the 2023 SITC Annual Meeting; FDA Greenlights Bria-OTS™ INDNASDAQ:BCTXWBriaCell Therapeutics Corporation
25/10/202315:15GlobeNewswire Inc.BriaCell Forms Medical Advisory Board of Distinguished Breast Cancer Specialists to Advance its Lead Oncology CandidateNASDAQ:BCTXWBriaCell Therapeutics Corporation
20/10/202315:15GlobeNewswire Inc.October is Breast Cancer Awareness Month – BriaCell is Leading the Fight with its Innovative TechnologyNASDAQ:BCTXWBriaCell Therapeutics Corporation
18/10/202315:00GlobeNewswire Inc.BriaCell Announces Presentations at the 2023 Society for the Immunotherapy of Cancer (SITC) and San Antonio Breast Cancer (SABC) ConferencesNASDAQ:BCTXWBriaCell Therapeutics Corporation
11/10/202315:10GlobeNewswire Inc.BriaCell To Host Virtual Key Opinion Leader Event on Bria-IMT™ Potential in Advanced Metastatic Breast Cancer on October 26, 2023 Featuring Dr. Adam M. Brufsky from University of Pittsburgh School of Medicine and Dr. Saranya Chumsri from Mayo ClinicNASDAQ:BCTXWBriaCell Therapeutics Corporation
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:BCTXW

La tua Cronologia

BIT
UC8ANF
Unicredit Bank
NASDAQ
FALPX
Franklin Growth And Inco...
TSX
PLDI
PIMCO Low duration Month...
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network